Jay Gajera

Jay Gajera

Auto-generated profile, based on publicly available information

Jay Gajera

Department of Neurology, Royal Children's Hospital, Parkville, Victoria, Australia; Department of Paediatrics, University of Melbourne, Parkville, Victoria, Australia

Research Focus & Metrics

Academic Career Length

7Years (2020-Present)

(Calculated once Scilit publication data is synced: current year − year of first publication + 1)

Representative Publications

View All Publications
13 October 2021 in Clinical Endocrinology
Verified
Journal Article
Closed access
PDF file
MGMatti Gild
Matti Gild
MCMico Chan
Mico Chan
JGJay Gajera
Jay Gajera
BLBrett Lurie
Brett Lurie
ZGZiba Gandomkar
Ziba Gandomkar
RCRoderick Clifton-Bligh
Roderick Clifton-Bligh

28 October 2021 in Scientific Data
Verified
Journal Article
Open access
PDF file
JTJennifer S. N. Tang
Jennifer S. N. Tang
JSJarrel C. Y. Seah
Jarrel C. Y. Seah
AZAdil Zia
Adil Zia
JGJay Gajera
Jay Gajera
RSRichard N. Schlegel
Richard N. Schlegel
MLMeng Law
Meng Law
Correct catheter position is crucial to ensuring appropriate function of the catheter and avoid complications. This paper describes a dataset consisting of 50,612 image level and 17,999 manually labelled annotations from 30,083 chest radiographs from the publicly available NIH ChestXRay14 dataset with manually annotated and segmented endotracheal tubes (ETT), nasoenteric tubes (NET) and central venous catheters (CVCs).

18 January 2022 in Journal of Cardiac Surgery
Verified
Journal Article
Closed access
PDF file
ADAtsuo Doi
Atsuo Doi
JGJay Gajera
Jay Gajera
DNDaniel Niewodowski
Daniel Niewodowski
SGShivanand Gangahanumaiah
Shivanand Gangahanumaiah
HWHelen Whitford
Helen Whitford
DMDavid McGiffin
David McGiffin

1 November 2021 in Neurointervention
Verified
Journal Article
Open access
PDF file
MFMichelle Foo
Michelle Foo
YRYifan Ren
Yifan Ren
JGJay Gajera
Jay Gajera
CBChristen D Barras
Christen D Barras
HKHong Kuan Kok
Hong Kuan Kok
HAHamed Asadi
Hamed Asadi
Purpose: Carotid artery stenting (CAS) is an established treatment for symptomatic carotid artery stenosis as an alternative to carotid endarterectomy. A variety of techniques and devices have been devised to minimise periprocedural stroke risk using either proximal or distal embolic protection. This study presents a method of embolic protection during CAS–the CaRotid Artery Filtering Technique (CRAFT).Materials and Methods: The CRAFT technique employs aspects of both proximal and distal embolic protection. The CASPER RX stent (MicroVention, Tustin, CA, USA), which is a double-layered, closed-cell, micromesh nitinol stent, is deployed across the carotid artery stenosis with the assistance of a FlowGate balloon guide catheter (Stryker Neurovascular, Fremont, CA, USA). The partially deployed stent acts as a distal filter while the balloon guide is deflated midway during stent deployment to prevent distal plaque embolisation, followed by completion of stent deployment and angioplasty.Results: A total of 94 patients underwent CAS using the CRAFT technique between June 2016 and March 2021. Successful stent deployment was achieved in all patients. Preliminary results demonstrated acute stent occlusion in 6 patients (6.4%) and distal embolic stroke in 5 patients (5.3%). The median procedural fluoroscopy time was 34 minutes with an interquartile range of 22 to 55 minutes.Conclusion: The CRAFT technique of CAS presented by this study can be applied in the treatment of symptomatic carotid artery stenosis in both emergency and elective procedure settings with a high technical success and low distal embolic stroke risk.

1 March 2022 in Neurointervention
Verified
Journal Article
Open access
PDF file
JGJay Gajera
Jay Gajera
JMJulian Maingard
Julian Maingard
MFMichelle Foo
Michelle Foo
YRYifan Ren
Yifan Ren
ALAnthony Lamanna
Anthony Lamanna
HAHamed Asadi
Hamed Asadi
Purpose: Advances in endovascular technology have expanded the treatment options for intracranial aneurysms. Intrasaccular flow diversion is a relatively new technique that aims to disrupt blood inflow at the neck of the aneurysm, hence promoting intrasaccular thrombosis. The Woven EndoBridge device (WEB; MicroVention, Aliso Viejo, CA, USA) is an US Food and Drug Administration approved intrasaccular flow diverter for wide-necked aneurysms. We report the early interim clinical and radiological outcomes of patients with both ruptured and unruptured intracranial aneurysms (IAs) treated using the WEB device in an Australian population.Materials and Methods: A retrospective analysis was done of patients with ruptured or unruptured IAs who received treatment with WEB across 5 Australian neuroendovascular referral centers between May 2017 and November 2020. Angiographic occlusion was assessed with time-of-flight magnetic resonance angiography. Complications were recorded and clinical outcomes were assessed using the modified Rankin scale at follow-up.Results: In total, 66 aneurysms were treated in 63 patients, with successful deployment of the WEB device in 98.5% (n=65). Eighteen (26.9%) ruptured aneurysms were included. Failure of deployment occurred in a single case. Adjunct coiling and/or stenting was performed in 20.9% (n=14) cases. Sixty-two patients with 65 aneurysms using a WEB device were followed up (mean=9.1 months), and 89.4% of these had complete aneurysm occlusion while 1.5% remained patent. Functional independence was achieved in 93.5% of cases.Conclusion: Early results following the use of WEB devices in Australia demonstrate safety and adequate aneurysm occlusion comparable to international literature.

15 May 2025 in Pediatric Neurology
Verified
Journal Article
Closed access
NFNicola D. Fearn
Nicola D. Fearn
MYMaggie L. Yau
Maggie L. Yau
JGJay Gajera
Jay Gajera
PMPaul Monagle
Paul Monagle
AGAnneke Grobler
Anneke Grobler
MMMark T. Mackay
Mark T. Mackay